Research & Development (R&D) Excellence
Innovating Formulations. Accelerating Global Healthcare.
At GJC Pharmaceuticals Pvt Ltd, our Research & Development division is the driving force behind innovation, quality, and global regulatory success. With a strong focus on complex generics, differentiated formulations, and regulatory-driven development, we deliver scalable and market-ready pharmaceutical solutions across multiple dosage forms.
Our R&D capabilities span Solid Oral, Injectable, Liquid, and Sachet dosage forms, supported by advanced technologies, scientific expertise, and compliance with WHO-GMP, EU, and international regulatory standards.
Our R&D Philosophy
- Innovation-led formulation development
- Quality by Design (QbD) approach
- Regulatory-first mindset (UK, EU, ROW markets)
- Faster time-to-market through robust development pipelines
- Lifecycle management & product differentiation
R&D plays a critical role in developing advanced drug delivery systems and improving product performance, safety, and patient compliance
Solid Oral Dosage Development
Capabilities:
- Tablets (IR, SR, CR, enteric-coated, bilayer)
- Capsules (hard gelatin, HPMC, softgel support)
- Orodispersible & chewable tablets
- Pellets, granules & multiparticulate systems
- Fixed-dose combinations (FDCs)
Technology Expertise:
- Wet & dry granulation, direct compression
- Pelletization (extrusion-spheronization)
- Bioavailability enhancement (solid dispersion, nano systems)
- Taste masking technologies
Solid oral systems enable controlled release, improved stability, and scalable manufacturing
Injectable (Parenteral) Development
Capabilities:
- Liquid injections (vials, ampoules, prefilled syringes)
- Lyophilized (freeze-dried) injections
- Depot & sustained-release injectables
- Complex sterile formulations
Core Strengths:
- Sterility assurance & aseptic processing
- Stability optimization for sensitive molecules
- Compatibility studies (container closure systems)
- Scale-up & technology transfer
Injectables are critical for biologics, peptides, and high-potency drugs where oral delivery is not feasible
Liquid Oral & Specialty Formulations
Capabilities:
- Syrups, suspensions, solutions
- Emulsions & drops
- Pediatric and geriatric formulations
- Ready-to-use and reconstitutable liquids
Expertise:
- Taste masking & flavor optimization
- Solubility enhancement for poorly soluble APIs
- Stability & preservative system design
Liquid dosage forms offer flexible dosing and faster absorption but require advanced stability control
Sachet & Powder Formulation Development
Capabilities:
- Oral powders & granules in sachets
- Effervescent formulations
- Nutraceutical & OTC sachets
- Reconstitution powders
Advantages:
- Accurate unit dosing
- Enhanced stability & portability
- Ideal for pediatrics and high-dose drugs
Sachets and granules provide flexible dosing and improved patient compliance
End-to-End R&D Capabilities
Pre-Formulation Studies
- API characterization
- Compatibility studies
- Excipient selection
Formulation Development
- Prototype development
- Optimization & scale-up
- Technology selection
Analytical Development
- Method development & validation
- Dissolution & impurity profiling
- Stability studies (ICH guidelines)
Regulatory Support
- CTD / eCTD dossier preparation
- Bioequivalence (BE) study support
- Global filings (UK, EU, ROW markets)
Why Choose GJC R&D?
- WHO-GMP compliant infrastructure
- Strong focus on UK/EU regulated markets
- Expertise in complex and niche formulations
- Faster development timelines
- Integrated approach from concept to commercialization
Our Vision
To become a globally trusted pharmaceutical R&D partner, delivering innovative, high-quality, and affordable medicines across international markets.
CTA Section
Partner with GJC Pharmaceuticals for advanced formulation development and global market success.
Contact our R&D team today to accelerate your product journey. fnd@gjcpharmaceutical.com ; info@gjcpharmaceutical.com; bd@gjcpharmaceutical.com
